You just read:

Nuvo Pharmaceuticals™ Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible Notes and Warrants

News provided by

Nuvo Pharmaceuticals Inc.

Mar 11, 2019, 07:30 ET